Resveratrol inhibits ionising irradiation-induced inflammation in MSCs by activating Sirt1 and limiting NLRP-3 inflammasome activation

International Journal of Molecular Sciences

Volumn 14, Issue 7, 2013, Pages 14105-14118

  Fu, Yue ^a   Wang, Yan ^a   Du, Liqing ^a   Xu, Chang ^a   Cao, Jia ^a   Fan, Tiqiang ^a   Liu, Jianxiang ^b   Su, Xu ^b   Fan, Saijun ^a   Liu, Qiang ^a   Fan, Feiyue ^a  

^a INSTITUTE OF RADIATION MEDICINE   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

IL 1 ; NLRP3; Radiation; Resveratrol; SIRT1

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; CRYOPYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; MESSENGER RNA; RESVERATROL; SIRTUIN 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL SWELLING; CLINICAL EFFECTIVENESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEACETYLATION; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; IONIZING RADIATION; MESENCHYMAL STEM CELL; MOLECULAR DYNAMICS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UPREGULATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRIER PROTEINS; CELLS, CULTURED; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; MESENCHYMAL STROMAL CELLS; NF-KAPPA B; NIACINAMIDE; RADIATION, IONIZING; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SIRTUIN 1; STILBENES; UP-REGULATION;

EID: 84880172098     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140714105     Document Type: Article

References (34)

1. Bernardo, M.E.; Fibbe, W.E. Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders. Ann. N. Y. Acad. Sci. 2012, 1266, 107-117.
2. Pittenger, M.F.; Mackay, A.M.; Beck, S.C.; Jaiswal, R.K.; Douglas, R.; Mosca, J.D.; Moorman, M.A.; Simonetti, D.W.; Craig, S.; Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284, 143-147.
3. Karp, J.M.; Teo, G.S.L. Mesenchymal stem cell homing: The devil is in the details. Cell Stem Cell 2009, 4, 206-216.
4. Xue, J.; Li, X.; Lu, Y.; Gan, L.; Zhou, L.; Wang, Y.; Lan, J.; Liu, S.; Sun, L.; Jia, L.; et al. Gene-modified mesenchymal stem cells protect against radiation-induced lung injury. Mol. Ther. 2013, 21, 456-465.
5. Lim, J.-Y.; Yi, T.; Choi, J.-S.; Jang, Y.H.; Lee, S.; Kim, H.J.; Song, S.U.; Kim, Y.-M. Intraglandular transplantation of bone marrow-derived clonal mesenchymal stem cells for amelioration of post-irradiation salivary gland damage. Oral Oncol. 2013, 49, 136-143.
6. Coppes, R.P.; Stokman, M.A. Stem cells and the repair of radiation-induced salivary gland damage. Oral Dis. 2011, 17, 143-153.
7. Yao, H.; Rahman, I. Perspectives on translational and therapeutic aspects of sirt1 in inflammaging and senescence. Biochem. Pharmacol. 2012, 84, 1332-1339.
8. Finkel, T.; Deng, C.-X.; Mostoslavsky, R. Recent progress in the biology and physiology of sirtuins. Nature 2009, 460, 587-591.
9. Michan, S.; Sinclair, D. Sirtuins in mammals: Insights into their biological function. Biochem. J. 2007, 404, 1-13.
10. Salminen, A.; Ojala, J.; Huuskonen, J.; Kauppinen, A.; Suuronen, T.; Kaarniranta, K. Interaction of aging-associated signaling cascades: Inhibition of nf-kappab signaling by longevity factors foxos and sirt1. Cell. Mol. Life Sci. 2008, 65, 1049-1058.
11. Lin, Q.-Q.; Yan, C.-F.; Lin, R.; Zhang, J.-Y.; Wang, W.-R.; Yang, L.-N.; Zhang, K.-F. Sirt1 regulates tnf-α-induced expression of cd40 in 3t3-l1 adipocytes via nf-κb pathway. Cytokine 2012, 60, 447-455.
12. Schroder, K.; Tschopp, J. The inflammasomes. Cell 2010, 140, 821-832.
13. Haneklaus, M.; O'Neill, L.A.J.; Coll, R.C. Modulatory mechanisms controlling the nlrp3 inflammasome in inflammation: Recent developments. Curr. Opin. Immunol. 2013, 25, 40-45.
14. Dostert, C.; Pétrilli, V.; Van Bruggen, R.; Steele, C.; Mossman, B.T.; Tschopp, J. Innate immune activation through nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320, 674-677.
15. Muruve, D.A.; Pétrilli, V.; Zaiss, A.K.; White, L.R.; Clark, S.A.; Ross, P.J.; Parks, R.J.; Tschopp, J. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 2008, 452, 103-107.
16. Duewell, P.; Kono, H.; Rayner, K.J.; Sirois, C.M.; Vladimer, G.; Bauernfeind, F.G.; Abela, G.S.; Franchi, L.; Nuñez, G.; Schnurr, M. et al. Nlrp3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464, 1357-1361.
17. Bauernfeind, F.G.; Horvath, G.; Stutz, A.; Alnemri, E.S.; MacDonald, K.; Speert, D.; Fernandes-Alnemri, T.; Wu, J.; Monks, B.G.; Fitzgerald, K.A. et al. Cutting edge: Nf-kappab activating pattern recognition and cytokine receptors license nlrp3 inflammasome activation by regulating nlrp3 expression. J. Immunol. 2009, 183, 787-791.
18. Zhou, R.; Tardivel, A.; Thorens, B.; Choi, I.; Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 2010, 11, 136-140.
19. Nakata, R.; Takahashi, S.; Inoue, H. Recent advances in the study on resveratrol. Biol. Pharm. Bull. 2012, 35, 273-279.
20. Gruber, J.; Tang, S.Y.; Halliwell, B. Evidence for a trade-off between survival and fitness caused by resveratrol treatment of caenorhabditis elegans. Ann. N. Y. Acad. Sci. 2007, 1100, 530-542.
21. Baur, J.A.; Pearson, K.J.; Price, N.L.; Jamieson, H.A.; Lerin, C.; Kalra, A.; Prabhu, V.V.; Allard, J.S.; Lopez-Lluch, G.; Lewis, K. et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444, 337-342.
22. Brasnyó, P.; Molnár, G.A.; Mohás, M.; Markó, L.; Laczy, B.; Cseh, J.; Mikolás, E.; Szijártó, I.A.; Mérei, A.; Halmai, R. et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the akt pathway in type 2 diabetic patients. Br. J. Nutr. 2011, 106, 383-389.
23. Bradamante, S.; Barenghi, L.; Villa, A. Cardiovascular protective effects of resveratrol. Cardiovasc. Drug Rev. 2004, 22, 169-188.
24. Zhang, H.; Zhai, Z.; Wang, Y.; Zhang, J.; Wu, H.; Wang, Y.; Li, C.; Li, D.; Lu, L.; Wang, X. et al. Resveratrol ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice. Free Radic. Biol. Med. 2013, 54, 40-50.
25. Chung, J.H.; Manganiello, V.; Dyck, J.R.B. Resveratrol as a calorie restriction mimetic: Therapeutic implications. Trends Cell Biol. 2012, 22, 546-554.
26. Şimşek, G.; Gürocak, S.; Karadaǧ, N.; Karabulut, A.B.; Demirtaş, E.; Karataş, E.; Pepele, E. Protective effects of resveratrol on salivary gland damage induced by total body irradiation in rats. Laryngoscope 2012, 122, 2743-2748.
27. Simsek, Y.; Gurocak, S.; Turkoz, Y.; Akpolat, N.; Celik, O.; Ozer, A.; Yilmaz, E.; Turhan, U.; Ozyalin, F. Ameliorative effects of resveratrol on acute ovarian toxicity induced by total body irradiation in young adult rats. J. Pediatr. Adolesc. Gynecol. 2012, 25, 262-266.
28. Park, S.-J.; Ahmad, F.; Philp, A.; Baar, K.; Williams, T.; Luo, H.; Ke, H.; Rehmann, H.; Taussig, R.; Brown, A.L. et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting camp phosphodiesterases. Cell 2012, 148, 421-433.
29. Yamamoto, H.; Schoonjans, K.; Auwerx, J. Sirtuin functions in health and disease. Mol. Endocrinol. 2007, 21, 1745-1755.
30. Zhu, X.; Liu, Q.; Wang, M.; Liang, M.; Yang, X.; Xu, X.; Zou, H.; Qiu, J. Activation of sirt1 by resveratrol inhibits tnf-α induced inflammation in fibroblasts. PLoS One 2011, 6, e27081.
31. Grishman, E.K.; White, P.C.; Savani, R.C. Toll-like receptors, the nlrp3 inflammasome, and interleukin-1β in the development and progression of type 1 diabetes. Pediatr. Res. 2012, 71, 626-632.
32. Calzado, M.A.; Bacher, S.; Schmitz, M.L. Nf-kappab inhibitors for the treatment of inflammatory diseases and cancer. Curr. Med. Chem. 2007, 14, 367-376.
33. Yang, L.; Zhang, J.; Yan, C.; Zhou, J.; Lin, R.; Lin, Q.; Wang, W.; Zhang, K.; Yang, G.; Bian, X. et al. Sirt1 regulates cd40 expression induced by tnf-α via nf-κb pathway in endothelial cells. Cell. Physiol. Biochem. 2012, 30, 1287-1298.
34. Lei, M.; Wang, J.-G.; Xiao, D.-M.; Fan, M.; Wang, D.-P.; Xiong, J.-Y.; Chen, Y.; Ding, Y.; Liu, S.-L. Resveratrol inhibits interleukin 1β-mediated inducible nitric oxide synthase expression in articular chondrocytes by activating sirt1 and thereby suppressing nuclear factor-κb activity. Eur. J. Pharmacol. 2012, 674, 73-79.